News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
LEE'S PHARM (00950.HK) Synthetic Surfactant Project Receives Funding from Gates Foundation
LEE'S PHARM (00950.HK) announced that it will receive financial funding from the Gates Foundation to support the Group's synthetic surfactant project.The short-term goal of the fun...
Reset
Send
The window will close in 5 seconds
LEE'S PHARM (00950.HK) Synthetic Surfactant Project Receives Funding from Gates Foundation
Close
Recommend
2
Positive
1
Negative
1
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

LEE'S PHARM (00950.HK)  -0.010 (-0.935%)   announced that it will receive financial funding from the Gates Foundation to support the Group's synthetic surfactant project.

The short-term goal of the funded project is to successfully complete the research and development of the active pharmaceutical ingredient (API) and formulation, as well as the manufacturing process of the drug. The ultimate objective is to introduce this life-saving drug to low- and middle-income countries at an affordable price, particularly to help premature infants suffering from respiratory distress syndrome. (sl/da)(HK stocks quote is delayed for at least 15 mins.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.